WallStreetZenWallStreetZen

NASDAQ: ANNX
Annexon Inc Stock Forecast, Predictions & Price Target

Analyst price target for ANNX

Based on 2 analysts offering 12 month price targets for Annexon Inc.
Min Forecast
$6.00+9.29%
Avg Forecast
$11.00+100.36%
Max Forecast
$16.00+191.44%

Should I buy or sell ANNX stock?

Based on 2 analysts offering ratings for Annexon Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ANNX stock forecasts and price targets.

ANNX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-21
lockedlocked$00.00+00.00%2023-12-21

1 of 1

Forecast return on equity

Is ANNX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.49%

Forecast return on assets

Is ANNX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ANNX revenue forecast

What is ANNX's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$37.8M
Avg 2 year Forecast
$91.3M
Avg 3 year Forecast
$227.4M

ANNX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANNX$5.49$11.00+100.36%Strong Buy
AKBA$1.54$4.50+192.21%Strong Buy
LYRA$5.48$14.00+155.47%Strong Buy
RAPT$8.66$21.33+146.34%Buy
XOMA$24.95$74.00+196.59%Buy

Annexon Stock Forecast FAQ

Is Annexon Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ANNX) stock is to Strong Buy ANNX stock.

Out of 2 analysts, 1 (50%) are recommending ANNX as a Strong Buy, 1 (50%) are recommending ANNX as a Buy, 0 (0%) are recommending ANNX as a Hold, 0 (0%) are recommending ANNX as a Sell, and 0 (0%) are recommending ANNX as a Strong Sell.

If you're new to stock investing, here's how to buy Annexon stock.

What is ANNX's revenue growth forecast for 2025-2027?

(NASDAQ: ANNX) Annexon's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 53.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.07%.

Annexon's revenue in 2024 is $0.On average, 3 Wall Street analysts forecast ANNX's revenue for 2025 to be $2,009,931,401, with the lowest ANNX revenue forecast at $783,145,469, and the highest ANNX revenue forecast at $3,349,796,936. On average, 2 Wall Street analysts forecast ANNX's revenue for 2026 to be $4,859,122,161, with the lowest ANNX revenue forecast at $1,657,329,603, and the highest ANNX revenue forecast at $8,060,914,719.

In 2027, ANNX is forecast to generate $12,104,415,630 in revenue, with the lowest revenue forecast at $12,104,415,630 and the highest revenue forecast at $12,104,415,630.

What is ANNX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ANNX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ANNX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ANNX price target, the average ANNX price target is $11.00, with the highest ANNX stock price forecast at $16.00 and the lowest ANNX stock price forecast at $6.00.

On average, Wall Street analysts predict that Annexon's share price could reach $11.00 by Dec 21, 2024. The average Annexon stock price prediction forecasts a potential upside of 100.36% from the current ANNX share price of $5.49.

What is ANNX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ANNX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.